Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading SNTA News...
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 2.03% | 17.60 | 14.2% | $409.51m | |
| SHPG | Shire PLC Sponsored ADR | -1.58% | 160.22 | 0.4% | $218.00m | |
| PRXL | PAREXEL International Corporation | -0.03% | 87.36 | 7.9% | $106.01m | |
| PTLA | Portola Pharmaceuticals, Inc. | 0.48% | 65.29 | 8.9% | $104.05m | |
| MNK | Mallinckrodt Plc | 4.06% | 46.69 | 17.7% | $93.51m | |
| PRGO | Perrigo Co. Plc | 3.92% | 75.50 | 6.4% | $87.48m | |
| JAZZ | Jazz Pharmaceuticals Plc | 2.38% | 159.85 | 2.2% | $69.43m | |
| UTHR | United Therapeutics Corporation | 0.08% | 131.36 | 13.9% | $67.14m | |
| ALR | Alere Inc. | 0.03% | 50.40 | 2.7% | $64.80m | |
| ENDP | Endo International Plc | 1.99% | 12.32 | 8.9% | $51.53m | |
| CTLT | Catalent Inc | -0.61% | 35.85 | 2.8% | $43.79m | |
| HZNP | Horizon Pharma plc | -0.77% | 12.91 | 7.6% | $43.55m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.74% | 128.66 | 22.1% | $43.21m | |
| MDCO | Medicines Company | 3.88% | 39.08 | 22.3% | $35.83m | |
| SAGE | SAGE Therapeutics, Inc. | 0.54% | 81.41 | 11.9% | $32.32m |
Company Profile
Madrigal Pharmaceuticals, Inc. clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel compounds for the treatment of cardiovascular, metabolic and liver diseases. The company offers MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Madrigal Pharmaceuticals was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.